OCD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with OCD (Obsessive-Compulsive Disorder) based on current official diagnostic guidelines (DSM-V and ICD-11)
- You are fluent in Czech
Who may not be able to join:
- You have any other psychiatric, neurological, or serious physical health condition
- You currently misuse or are dependent on substances (such as alcohol or drugs)
- You are taking certain medications that affect mood or mental state, such as sedatives like benzodiazepines — note that antidepressants, antipsychotics, and sleep medications are exceptions and may be allowed (confirm with trial site)
- You have a condition that makes using virtual reality unsafe for you, such as epilepsy or balance problems
- You are currently pregnant
- You have a heart pacemaker or any metal implants in your body
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Iveta Hocko Fajnerová, Ph.D., National Institute of Mental Health (NIMH)
Phone: +420608501034
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) self report version; The Beck Depression Inventory; Beck Anxiety Inventory (BAI); Hierarchy of fears; The Spielberger State-Trait Anxiety Inventory-X2 (STAI-X2)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.